JP2001520521A5 - - Google Patents

Download PDF

Info

Publication number
JP2001520521A5
JP2001520521A5 JP1998545227A JP54522798A JP2001520521A5 JP 2001520521 A5 JP2001520521 A5 JP 2001520521A5 JP 1998545227 A JP1998545227 A JP 1998545227A JP 54522798 A JP54522798 A JP 54522798A JP 2001520521 A5 JP2001520521 A5 JP 2001520521A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998545227A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001520521A (ja
Filing date
Publication date
Priority claimed from GBGB9705903.4A external-priority patent/GB9705903D0/en
Application filed filed Critical
Publication of JP2001520521A publication Critical patent/JP2001520521A/ja
Publication of JP2001520521A5 publication Critical patent/JP2001520521A5/ja
Ceased legal-status Critical Current

Links

JP54522798A 1997-03-21 1998-03-23 Vp22タンパク質及びその使用 Ceased JP2001520521A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9705903.4 1997-03-21
GBGB9705903.4A GB9705903D0 (en) 1997-03-21 1997-03-21 VP22 Proteins and uses thereof
PCT/GB1998/000873 WO1998042742A1 (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof

Publications (2)

Publication Number Publication Date
JP2001520521A JP2001520521A (ja) 2001-10-30
JP2001520521A5 true JP2001520521A5 (https=) 2005-11-10

Family

ID=10809645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54522798A Ceased JP2001520521A (ja) 1997-03-21 1998-03-23 Vp22タンパク質及びその使用

Country Status (7)

Country Link
US (2) US20020128174A1 (https=)
EP (1) EP0971953A1 (https=)
JP (1) JP2001520521A (https=)
AU (1) AU6739398A (https=)
CA (1) CA2283794A1 (https=)
GB (1) GB9705903D0 (https=)
WO (1) WO1998042742A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423334B1 (en) 1997-10-01 2002-07-23 Elan Corporation, Plc Composition and method for enhancing transport across gastrointestinal tract cell layers
GB9816761D0 (en) 1998-07-31 1998-09-30 Phogen Limited Herpesvirus preparations and their uses
DE60040274D1 (de) * 1999-03-10 2008-10-30 Phogen Ltd Verabreichung von nukleinsäuren und proteinen an zellen
US6358739B1 (en) 1999-04-12 2002-03-19 Modex Therapeutiques, S.A. Transiently immortalized cells
US6451601B1 (en) 1999-04-12 2002-09-17 Modex Therapeutiques, S.A. Transiently immortalized cells for use in gene therapy
GB9930519D0 (en) * 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins
US6688084B2 (en) * 2000-03-24 2004-02-10 International Paper Company Automated bulk box strapper
BRPI0406647A (pt) * 2003-01-06 2005-12-06 Angiochem Inc Método para transportar um composto através da barreira sanguìnea do cérebro
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
TR201905480T4 (tr) 2008-04-18 2019-05-21 Angiochem Inc Paklitaksel, paklitaksel analogları veya paklitaksel konjugatlarının farmasötik bileşimleri ve ilgili preparasyon ve kullanım yöntemleri.
MX2011004019A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de etoposido y doxorubicina para entrega de farmacos.
BRPI0920209A2 (pt) 2008-10-15 2015-12-22 Angiochem Inc conjugados de agonistas de glp-1 e usos dos mesmos
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
WO2010121379A1 (en) 2009-04-20 2010-10-28 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
AU2010268726A1 (en) 2009-07-02 2012-01-19 Angiochem Inc. Multimeric peptide conjugates and uses thereof
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5278324A (en) 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5059699A (en) 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
TW223634B (https=) 1991-03-18 1994-05-11 Kingston David G I
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
CA2128693A1 (en) 1992-01-31 1993-08-05 Peter B. Schiff Taxol as a radiation sensitizer
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
US5631278A (en) 1992-12-02 1997-05-20 Thomas Jefferson University Methods of killing protozoal parasites
US5356927A (en) 1992-12-02 1994-10-18 Thomas Jefferson University Methods of treating plasmodium and babesia parasitic infections
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
BR9610058A (pt) * 1995-07-28 1999-07-27 Marie Curie Cancer Care Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
US6017735A (en) * 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses

Similar Documents

Publication Publication Date Title
JP2000509635A5 (https=)
JP2000509912A5 (https=)
JP2000510751A5 (https=)
JP2000509637A5 (https=)
JP2000509942A5 (https=)
JP2002510434A5 (https=)
JP2000509587A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2002511746A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510969A5 (https=)
JP2000510247A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509520A5 (https=)
JP2000509818A5 (https=)
JP2000507434A5 (https=)
JP2001525863A5 (https=)
JP2001520521A5 (https=)